350 related articles for article (PubMed ID: 25841699)
21. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
[TBL] [Abstract][Full Text] [Related]
22. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
23. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial routing of glucose and sucrose polymers after pinocytotic uptake: avenues for drug delivery.
Rashid R; Beyer S; Blocki A; Le Visage C; Trau D; Wohland T; Raghunath M
Biomacromolecules; 2014 Jun; 15(6):2119-27. PubMed ID: 24809225
[TBL] [Abstract][Full Text] [Related]
25. Gold nanoparticles: emerging paradigm for targeted drug delivery system.
Kumar A; Zhang X; Liang XJ
Biotechnol Adv; 2013; 31(5):593-606. PubMed ID: 23111203
[TBL] [Abstract][Full Text] [Related]
26. Targeting mitochondria.
Hoye AT; Davoren JE; Wipf P; Fink MP; Kagan VE
Acc Chem Res; 2008 Jan; 41(1):87-97. PubMed ID: 18193822
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
[TBL] [Abstract][Full Text] [Related]
28. Critical gases for critical issues: CO2 technologies for oral drug delivery.
Danan H; Esposito P
Ther Deliv; 2014 Feb; 5(2):205-32. PubMed ID: 24483197
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
30. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
[TBL] [Abstract][Full Text] [Related]
31. Nanostructure-mediated drug delivery.
Hughes GA
Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
[TBL] [Abstract][Full Text] [Related]
32. The role of mitochondrial dysfunction and drug safety.
Nadanaciva S; Will Y
IDrugs; 2009 Nov; 12(11):706-10. PubMed ID: 19844857
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria-targeted drug delivery in cancers.
Cho H; Cho YY; Shim MS; Lee JY; Lee HS; Kang HC
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165808. PubMed ID: 32333953
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol affects differently rat liver and brain mitochondrial bioenergetics and oxidative stress in vitro: investigation of the role of gender.
Moreira AC; Silva AM; Santos MS; Sardão VA
Food Chem Toxicol; 2013 Mar; 53():18-26. PubMed ID: 23200887
[TBL] [Abstract][Full Text] [Related]
35. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
36. Fabrication of solid nanoparticles for drug delivery.
Arayne MS; Sultana N; Noor-Us-Sabah
Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113
[TBL] [Abstract][Full Text] [Related]
37. From serendipity to mitochondria-targeted nanocarriers.
Weissig V
Pharm Res; 2011 Nov; 28(11):2657-68. PubMed ID: 21833792
[TBL] [Abstract][Full Text] [Related]
38. [Role of transmembrane GTPases in mitochondrial morphology and activity].
Pawlikowska P; Orzechowski A
Postepy Biochem; 2007; 53(1):53-9. PubMed ID: 17718388
[TBL] [Abstract][Full Text] [Related]
39. [Advances in mitochondrial fusion-fission and Ca2+ signaling in mammals].
Zhao GJ; Lu ZQ; Yao YM
Sheng Li Ke Xue Jin Zhan; 2010 Jun; 41(3):171-6. PubMed ID: 21416975
[TBL] [Abstract][Full Text] [Related]
40. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
